COMPANY OVERVIEW

None

---

LOCATION

---

THERAPEUTIC AREAS

---

WEBSITE

None

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

PRESS RELEASES

Dec 9, 2021

OncoPep Completes $11 Million Series D Financing to Continue Clinical Trials and Advance Pipeline Development

Nov 9, 2021

Carl Novina, MD, PhD, Joins OncoPep Scientific Advisory Board

Oct 15, 2020

OncoPep Strengthens Pipeline with Addition of Multi-Tumor Antigen Adoptive T Cell Therapy

Aug 8, 2018

OncoPep Announces a Phase 1b Clinical Trial of Its Multi-Peptide Cancer Vaccine PVX-410 in Combination with Citarinostat for Smoldering Multiple Myeloma

Feb 22, 2018

OncoPep Announces Initiation of Phase 1b Clinical Trial of PVX-410 in Metastatic Triple Negative Breast Cancer

For More Press Releases

---